This is the authors' abstract. We don't add key points for this paper.
Critical to the development of an effective HIV vaccine is the identification of adaptive immune responses that prevent infection or disease. In this study we demonstrate in a relevant nonhuman primate model of AIDS that the magnitude of vaccine-induced virus-specific CD8(+) central memory T cells (T(CM)), but not that of CD8(+) effector memory T cells, inversely correlates with the level of SIVmac251 replication, suggesting their pivotal role in the control of viral replication. We propose that effective preventive or therapeutic T cell vaccines for HIV-1 should induce long-term protective central memory T cells.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Vaccari et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: